The final episode:
a masterclass in rare
disease sequencing.
This is Episode 4 of 4. Sign up to unlock the full series.
Rare disease cases are notoriously tricky. Alex Hoischen knows – he’s built a career solving the ones that others gave up on. In this final episode, get his unfiltered take on why every lab needs long-read sequencing.
The final episode: a masterclass in rare disease sequencing
This is Episode 4 of 4. Sign up to unlock the full series.
Rare disease cases are notoriously tricky. Alex Hoischen knows – he’s built a career solving the ones that others gave up on. In this final episode, get his unfiltered take on why every lab needs long-read sequencing.

What every clinical lab needs to hear right now.
You’re one click from four expert interviews, in four different fields, with one rare chance to see the tools shaping modern genomics.
Rare disease expert Alex Hoischen shares what others miss – from structural variants to deep intronic mutations and how clinical labs can rethink their entire approach using long-read genomes.
It’s your last chance to access the series – and the clearest view of where rare disease research is going next.
Sign up to watch the
interview + get bonus
resources to use now
Includes all episodes in the series.
Trouble loading the form? Register here.
What you’ll get with sign-up


Case
closed
Hear first-hand accounts of mysterious disorders finally explained by long-read sequencing.
Short reads
aren’t enough
See what’s missing in standard testing, and why it’s costing patients time.
HiFi as a
first-line test
See how Alex’s team is helping to reshape diagnostics with more complete, confident data.



Pacific Biosciences of California, Inc. — 1305 O’Brien Dr., Menlo Park, CA 94025 Research use only. Not for use in diagnostic procedures. © 2026 PacBio. All rights reserved. Legal + trademarks and privacy policy.
Follow us
